Structure-based de novo design of novel inhibitors of the MDM2-p53 interaction

被引：0

作者：

Sun, Daqing ^{[1
]}

Rew, Yosup ^{[1
]}

De Turiso, Felix Gonzalez Lopez ^{[1
]}

Bartberger, Michael D. ^{[3
]}

Beck, Hilary P. ^{[1
]}

Canon, Jude ^{[4
]}

Chen, Ada ^{[1
]}

Chow, David ^{[1
]}

Deignan, Jeffrey ^{[1
]}

Fox, Brian M. ^{[1
]}

Huang, Xin ^{[5
]}

Jiang, Min ^{[2
]}

Jiao, Xianyun ^{[1
]}

Jin, Lixia ^{[2
]}

Kopecky, David J. ^{[1
]}

Li, Yihong ^{[1
]}

Lo, Mei-Chu ^{[1
]}

Long, Alexander M. ^{[5
]}

Michelsen, Klaus ^{[3
]}

Oliner, Jonathan D. ^{[4
]}

Osgood, Tao ^{[4
]}

Saiki, Anne Y. ^{[4
]}

Schneider, Steve ^{[5
]}

Yakowec, Peter ^{[5
]}

Yan, Xuelei ^{[1
]}

Ye, Qiuping ^{[2
]}

Yu, Dongyin ^{[4
]}

Zhao, Xiaoning ^{[1
]}

Zhou, Jing ^{[1
]}

Olson, Steven H. ^{[1
]}

Medina, Julio C. ^{[1
]}

机构：

[1] Amgen Inc, Therapeut Discovery, San Francisco, CA 94080 USA

[2] Amgen Inc, Pharmacokinet & Drug Metab, San Francisco, CA 94080 USA

[3] Amgen Inc, Therapeut Discovery, Thousand Oaks, CA 91320 USA

[4] Amgen Inc, Oncol Res, Thousand Oaks, CA 91320 USA

[5] Amgen Inc, Therapeut Discovery, Cambridge, MA 02142 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 246卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页数：1

共 50 条

[1] Structure-Based Design of Novel Inhibitors of the MDM2-p53 Interaction
Rew, Yosup
Sun, Daqing
De Turiso, Felix Gonzalez-Lopez
Bartberger, Michael D.
Beck, Hilary P.
Canon, Jude
Chen, Ada
Chow, David
Deignan, Jeffrey
Fox, Brian M.
Gustin, Darin
Huang, Xin
Jiang, Min
Jiao, Xianyun
Jin, Lixia
Kayser, Frank
Kopecky, David J.
Li, Yihong
Lo, Mei-Chu
Long, Alexander M.
Michelsen, Klaus
Oliner, Jonathan D.
Osgood, Tao
Ragains, Mark
Saiki, Anne Y.
Schneider, Steve
Toteva, Maria
Yakowec, Peter
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Medina, Julio C.
Olson, Steven H.
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) : 4936 - 4954
[2] Discovery of AM-8553: Structure-based design of novel piperidinone inhibitors of the MDM2-p53 interaction
Rew, Yosup
Sun, Daqing
De Turiso, Felix Gonzalez Lopez
Bartberger, Michael D.
Beck, Hilary P.
Canon, Jude
Chen, Ada
Chow, David
Deignan, Jeffrey
Fox, Brian M.
Gustin, Darin
Huang, Xin
Jiang, Min
Jiao, Xianyun
Jin, Lixia
Kayser, Frank
Kopecky, David J.
Li, Yihong
Lo, Mei-Chu
Long, Alexander M.
Michelsen, Klaus
Oliner, Jonathan D.
Osgood, Tao
Ragains, Mark
Saiki, Anne Y.
Schneider, Steve
Toteva, Maria
Yakowec, Peter
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Medina, Julio C.
Olson, Steven H.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[3] Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein-Protein Interaction
Chessari, Gianni
Hardcastle, Ian R.
Ahn, Jong Sook
Anil, Burcu
Anscombe, Elizabeth
Bawn, Ruth H.
Bevan, Luke D.
Blackburn, Timothy J.
Buck, Ildiko
Cano, Celine
Carbain, Benoit
Castro, Juan
Cons, Ben
Cully, Sarah J.
Endicott, Jane A.
Fazal, Lynsey
Golding, Bernard T.
Griffin, Roger J.
Haggerty, Karen
Harnor, Suzannah J.
Hearn, Keisha
Hobson, Stephen
Holvey, Rhian S.
Howard, Steven
Jennings, Claire E.
Johnson, Christopher N.
Lunec, John
Miller, Duncan C.
Newell, David R.
Noble, Martin E. M.
Reeks, Judith
Revill, Charlotte H.
Riedinger, Christiane
St Denis, Jeffrey D.
Tamanini, Emiliano
Thomas, Huw
Thompson, Neil T.
Vinkovic, Mladen
Wedge, Stephen R.
Williams, Pamela A.
Wilsher, Nicola E.
Zhang, Bian
Zhao, Yan
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (07) : 4071 - 4088
[4] Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction
Ding, Ke
Lu, Yipin
Nikolovska-Coleska, Zaneta
Wang, Guoping
Qiu, Su
Shangary, Sanjeev
Gao, Wei
Qin, Dongguang
Stuckey, Jeanne
Krajewski, Krzysztof
Roller, Peter P.
Wang, Shaomeng
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (12) : 3432 - 3435
[5] From de novo design to the clinic: The discovery of AMG 232, an inhibitor of the MDM2-p53 interaction
Olson, Steven
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[6] Inhibitors of the MDM2-p53 interaction as anticancer drugs
Hardcastle, Ian R.
DRUGS OF THE FUTURE, 2007, 32 (10) : 883 - 896
[7] The MDM2-p53 interaction
Moll, UM
Petrenko, O
MOLECULAR CANCER RESEARCH, 2003, 1 (14) : 1001 - 1008
[8] Novel inhibitors of the MDM2-p53 interaction featuring carboxylic acid isosteres
Gonzalez, Ana Z.
Li, Zhihong
Beck, Hilary P.
Canon, Jude
Chen, Ada
Chow, David
Duquette, Jason
Eksterowicz, John
Fox, Brian M.
Fu, Jiasheng
Huang, Xin
Houze, Jonathan
Jin, Lixia
Li, Yihong
Ling, Yun
Lo, Mei-Chu
Long, Alexander M.
Mcgee, Lawrence R.
McIntosh, Joel
Oliner, Jonathan D.
Osgood, Tao
Rew, Yosup
Saiki, Anne Y.
Shaffer, Paul
Wortman, Sarah
Yakowec, Peter
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Olson, Steven H.
Sun, Daqing
Medina, Julio C.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
[9] Structure-based design of potent, non-peptide small-molecule inhibitors of the MDM2-p53 interaction starting from an inactive lead
Wang, Shaomeng
Ding, Ke
Lu, Yipin
Nikolovska-Coleska, Zaneta
Qiu, Su
Kumar, Sanjeev
Roller, Peter P.
Tomita, York
Krajewski, Krzysztof
Deschamps, Jeffrey R.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2700 - U2700
[10] Selective and potent morpholinone inhibitors of the MDM2-p53 interaction
Gonzalez, Ana Z.
Eksterowics, John
Beck, Hilary P.
Canon, Jude
Chen, Ada
Chow, David
Duquette, Jason
Fox, Brian M.
Fu, Jiasheng
Houze, Jonathan
Jin, Lixia
Li, Yihong
Li, Zhihong
Lo, Mei-Chu
Long, Alexander M.
McGee, Lawrence R.
McIntosh, Joel
Oliner, Jonathan D.
Osgood, Tao
Rew, Yosup
Saiki, Anne Y.
Shaffer, Paul
Wortman, Sarah
Yakowek, Peter
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Olson, Steven H.
Medina, Julio C.
Sun, Daqing
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246

← 1 2 3 4 5 →